Orthopedic Market Intelligence Report 2020 - COVID-19, Joint Replacement, Spine, Trauma, Sports Medicine, Orthobiologics, Contract Manufacturing
DUBLIN, June 17, 2020 /PRNewswire/ -- The "The Orthopaedic - Orthopedic Industry Market Report" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
This report is the definitive source for orthopedic market intelligence.
Special Features of the 2020 Installment Include:
-- COVID-19 Impact and Recovery Insights -- Data for Companies with Revenue >$100 Million -- Bonus Excel File of Raw Numbers
Within this report, you'll find:
-- Eighty revenue and market share exhibits that are also presented in a standalone Excel file. These include: -- 2019 vs. 2018 revenue estimates for the 43 largest companies (revenue above $199 million) and market share for the top seven -- 2019 vs. 2018 revenue estimates and market share for the top players in each market segment (joint replacement knee, hip, and extremities; spine; trauma; sports medicine; orthobiologics and contract manufacturers) -- 2019 U.S., EMEA, Asia Pacific and Rest of World revenue for the top thirteen companies and others -- Growth rates for the largest players in each segment -- 2017 through 2022 year-over-year projections for the industry overall and each market segment -- A summary of influences that shape the industry and each market segment -- A recap of 2019 strategic activity, including acquisitions, FDA 510(k) clearances, product launches, and funding -- Lists of companies that play in each market segment and the subsegments within which they sell products -- Market drivers and advice regarding the current and critical opportunities and challenges driving the industry. These include: -- The COVID-19 pandemic -- Ambulatory Surgical Centers (ASCs) and outpatient care settings -- New materials -- Mergers & acquisitions in companies and hospitals -- Robotics, computer-assisted surgery and connected ecosystems of products
A Contract Manufacturing chapter that details the sector's size and market forces. These companies are seen as an extension of device manufacturers' operations; therefore, they face similar market influences, including consolidation, global expansion, and personnel challenges.
A list of companies that received their first FDA 510(k) clearances and companies that received their first 510(k) clearance in a new market segment, as well as details on the company's product and headquarter country.
Venture capitalists, financial analysts, device companies, suppliers, consultants, and entrepreneurial-minded surgeons utilize components of this report to set strategy, prioritize actions and move their companies, their initiatives, and their careers-forward.
Users tell us that they use the report to:
-- Identify Acquisition Targets and New Customers -- Improve Sales Forecasts -- Bolster Business Plans -- Refine Competitive Analysis -- Expand Your Perspective on Crucial Orthopedic Market Dynamics -- Advance Your Position Inside and Outside Your Company -- Educate New Hires and Veteran Team Members
Key Topics Covered
PREFACE
NUMBERS AND SEGMENTS
EXECUTIVE SUMMARY
-- Situation Analysis -- Performance Overview -- Product Segments -- Exhibit 1: Orthopedic Product Segment Sales - 2017 to 2019 -- Exhibit 2: Market Share by Product Segment - 2017 to 2019 -- Exhibit 3: Orthopedic Product Segment Sales by 2019 Market Share -- Company Performance -- Exhibit 4: Total Orthopedic Product Sales - 2017 to 2019 -- Exhibit 5: Market Share - Largest Players and All Others -- Exhibit 6: Top Tier Company Sales by Market Segment -- Exhibit 7: Total Orthopedic Sales - Players Between $400 and $999 Million -- Exhibit 8: Total Orthopedic Sales - Companies Over $400 Million -- Exhibit 9: Growth Rates for the Largest Orthopedic Companies -- Exhibit 10: Total Orthopedic Sales - Players Between $200 and $399 Million -- Exhibit 11: Total Orthopedic Sales - Players Between $100 and $199 Million -- Exhibit 12: Orthopedic Sales by Geographic Region -- Exhibit 13: Orthopedic Sales Performance by Geographic Region -- Market Forecasts -- Exhibit 14: Orthopedic Sales - 2017 to 2022 -- Exhibit 15: Orthopedic Sales Trajectory - 2017 to 2022
JOINT REPLACEMENT
-- Market & Players Review -- Exhibit 16: Joint Replacement Market Share -- Exhibit 17: Joint Replacement Sales - 2017 to 2019 -- Exhibit 18: Joint Replacement Sales by Segment -- Exhibit 19: Joint Replacement Sales - Players Over $100 Million and All Others -- Exhibit 20: Joint Replacement Market Share - Top 10 Players and All Others -- Exhibit 21: Largest Joint Replacement Companies by Revenue -- Exhibit 22: Growth Rates for the Largest Joint Replacement Companies by Revenue -- Robotics and Enabling Technologies in Joint Replacement -- Knees -- Exhibit 23: Knee Market Share -- Exhibit 24: Knee Sales - 2017 to 2019 -- Exhibit 25: Knee Sales - Players Over $50 Million and All Others -- Exhibit 26: Knee Market Share - Top 10 Players and All Others -- Exhibit 27: 10 Largest Knee Companies by Revenue -- Exhibit 28: Growth Rates for the 10 Largest Knee Companies -- Hips -- Exhibit 29: Hip Market Share -- Exhibit 30: Hip Sales - 2017 to 2019 -- Exhibit 31: Hip Sales - Players Over $50 Million and All Others -- Exhibit 32: Hip Market Share - Top 10 Players and All Others -- Exhibit 33: 10 Largest Hip Companies by Revenue -- Exhibit 34: Growth Rates for the 10 Largest Hip Players -- Extremities -- Exhibit 35: Extremities Joint Market Share -- Exhibit 36: Extremities Joint Sales - 2017 to 2019 -- Exhibit 37: Extremities Joint Sales - Players Over $50 Million and All Others -- Exhibit 38: Extremities Market Share - Top 9 Players and All Others -- Exhibit 39: 9 Largest Extremities Companies by Revenue -- Exhibit 40: Growth Rates for the 9 Largest Extremities Companies -- Joint Replacement Market Forecast -- Exhibit 41: Joint Replacement Sales - 2017 to 2022 -- Exhibit 42: Joint Replacement Sales Trajectory - 2017 to 2022 -- Companies to Watch -- Corin Enters Robotics Market with OMNI Acquisition -- LimaCorporate Expands Enabling Technology, 3D Printing Portfolio -- DT MedTech Expands with New Total Ankle in U.S. Market -- Product Launches & Technologies -- Strategic Product Launches in 2019 -- Companies with First FDA 510(k) in 2019
SPINE
-- Market & Players Review Exhibit 43: Spine Market Share -- Exhibit 44: Spine Sales - 2017 to 2019 -- Exhibit 45: Spine Sales by Segments -- Exhibit 46: Spine Sales - Players Over $50 Million and All Others -- Exhibit 47: Spine Sales Growth Rates - Spine Focused and Diversified Players -- Exhibit 48: Spine Market Share - Top 11 Players and All Others -- Market Forecast -- Exhibit 49: Spine Sales - 2017 to 2022 -- Exhibit 50: Spine Sales Trajectory - 2017 to 2022 -- Companies to Watch -- ATEC's Painful Road Back to Relevance in Spine -- MiRus Receives FDA 510(k) Clearance for Implant with New Superalloy -- SI-BONE Double-Digit Growth Fueled by Reimbursement Wins -- Product Launches & Technologies -- Strategic Product Launches in 2019 -- Companies with First FDA 510(k) in 2019
TRAUMA
-- Market & Players Review -- Exhibit 51: Trauma Market Share -- Exhibit 52: Trauma Sales - 2017 to 2019 -- Exhibit 53: Trauma Sales - Players Over $50 Million and All Others -- Exhibit 54: 12 Largest Trauma Players by Sales -- Exhibit 55: Trauma Market Share - Top 12 Players and All Others -- Exhibit 56: Growth Rates for the 12 Largest Trauma Companies -- Market Forecast -- Exhibit 57: Trauma Sales - 2017 to 2022 -- Exhibit 58: Trauma Sales Trajectory - 2017 to 2022 -- Companies to Watch -- OrthoPediatrics Eyeing $100 Million Mark, $50 Million in Trauma -- Paragon 28 Growth Backed by Aggressive Product Development -- Product Launches & Technologies -- Strategic Product Launches in 2019 -- Companies with First FDA 510(k) in 2019
SPORTS MEDICINE
-- Market & Players Review -- Exhibit 59: Sports Medicine Market Share -- Exhibit 60: Sports Medicine Sales - 2017 to 2019 -- Exhibit 61: Sports Medicine Sales - Players Over $100 Million and All Others -- Exhibit 62: 7 Largest Sports Medicine Companies by Revenue -- Exhibit 63: Sports Medicine Market Share - Top 7 Players and All Others -- Exhibit 64: Growth Rates for the 7 Largest Sports Medicine Companies -- Market Forecast -- Exhibit 65: Sports Medicine Sales - 2017 to 2022 -- Exhibit 66: Sports Medicine Sales Trajectory - 2017 to 2022 -- Companies to Watch -- ConMed Looks to New Products and Sales Structure to Maintain Growth -- Anika Diversifies Revenue Mix Through Regenerative Medicine -- Product Launches & Technologies -- Strategic Product Launches in 2019 -- Companies with First FDA 510(k) in 2019
ORTHOBIOLOGICS
-- Market & Players Review -- Exhibit 67: Orthobiologics Market Share -- Exhibit 68: Orthobiologics Sales - 2017 to 2019 -- Exhibit 69: Orthobiologics Sales - Players Over $50 Million and All Others -- Exhibit 70: Orthobiologics Market Share - Top 11 Players and All Others -- Exhibit 71: 11 Largest Orthobiologics Companies by Revenue -- Exhibit 72: Growth Rates for the 11 Largest Orthobiologics Companies -- Market Forecast Exhibit 73: Orthobiologics Sales - 2017 to 2022 -- Exhibit 74: Orthobiologics Sales Trajectory - 2017 to 2022 -- Companies to Watch -- SeaSpine Doubles Down on DBMS with OsteoStrand -- Vericel: A High Growth Story with Staying Power -- Product Launches & Technologies -- Strategic Product Launches in 2019
CONTRACT MANUFACTURING
-- Market & Players Review Exhibit 75: Contract Manufacturing Orthopedic Sales - 2017 to 2019 -- Exhibit 76: Contract Manufacturing Orthopedic Sales - Players Over $100 Million -- Exhibit 77: Contract Manufacturing Orthopedic Market Share - Top 7 Players and All Others -- Exhibit 78: Top 10 Contract Manufacturers by Orthopedic Revenue Rank -- Market Forecast -- Exhibit 79: Contract Manufacturing Sales - 2017 to 2022 -- Exhibit 80: Contract Manufacturing Trajectory - 2017 to 2022 -- Companies to Watch -- Jabil Creates Formal Healthcare Group -- Lincotek Positioned as a Top Supplier with CoorsTek Acquisition -- Capability and Certification Expansions -- Equipment and Facility Expansions
APPENDICES
Appendix A: 2019 FDA 510(K)s
Appendix B: 2019 Funding
Appendix C: Contract Manufacturer M&A
Appendix D: Device and Orthobiologic Company M&A
Appendix E: Joint Replacement
Appendix F: Spine
Appendix G: Trauma
Appendix H: Sports Medicine
Appendix I: Orthobiologics
Appendix J: Robotics & Digital Surgery
Companies Mentioned
-- Acumed -- Aesculap -- Alphatec/ATEC Spine -- Amplitude -- Anika Therapeutics -- Arthrex -- Arthrosurface -- Autocam Medical -- Avalign -- Bioventus -- CeramTec -- Conformis -- ConMed -- Corin -- Cretex Companies -- CrossRoads Extremity Systems -- DePuy Synthes -- DJO -- Elos Medtech -- EOS imaging -- Episurf Medical -- Evolutis -- Exactech -- Globus Medical -- GS Medical -- HAPPE Spine -- Heraeus -- Implantcast -- Intech -- Integra LifeSciences -- KARL STORZ -- Kyocera -- LifeNet Health -- LimaCorporate -- Mathys -- Medacta -- Medartis -- Medtronic -- MicroPort Orthopedics -- MiRus -- MTF Biologics -- NN Life Sciences -- NuVasive -- Orchid Orthopedic Solutions -- Orthofix Medical -- OrthoPediatrics -- OsteoMed -- RTI Surgical -- SeaSpine -- Seikagaku -- Smith & Nephew -- Spineart -- Stryker -- Tecomet -- ulrich medical -- Viant -- Waldemar Link -- WishBone Medical -- Wright Medical -- Zimmer Biomet
For more information about this report visit https://www.researchandmarkets.com/r/m3787u
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/orthopedic-market-intelligence-report-2020---covid-19-joint-replacement-spine-trauma-sports-medicine-orthobiologics-contract-manufacturing-301078948.html
SOURCE Research and Markets